'''Katemera wa Hepataitisi B''' ndi [[vaccine|katemera]] amene amathandiza kupewa matenda a [[hepatitis B|hepataitisi B]].<ref name="WHO20092">{{cite journal|title=Hepatitis B vaccines WHO position paper|journal=Weekly epidemiological record|date=2 Oct 2009|volume=40|issue=84|page=405-420|url=http://www.who.int/wer/2009/wer8440.pdf}}</ref> Mwana aliyense akangobadwa amayenera kupatsidwa katemerayu pasanapite maola 24 mwanayo atabadwa, ndipo kenako angalandire katemera wachiwiri ndiponso wachitatu pakapita nthawi.<!-- <ref name=WHO2009/> --> Ngakhale ana omwe ali ndi [[Immunosuppression|chitetezo chochepa m'thupi]] mwina chifukwa cha [[HIV/AIDS]] kapena omwe [[Premature infant|anabadwa masiku asanakwane]]  ayenera kulandira katemerayu.<!-- <ref name=WHO2009/> --> Kwa anthu omwe alibe mavuto  ena m'thupi, katemerayu amathandiza kwambiri moti anthu 95 pa 100 aliwonse amene alandira katemerayu sangadwale.<ref name="WHO20092" /><!-- Administration -->

Anthu omwe ali m'madera amene matendawa ndi ofala kwambiri amayenera kuyezetsa magazi kuti atsimikizire ngati katemerayu akugwira bwino ntchito.<!-- <ref name=WHO2009/> --> Ndipo anthu a m'mayiko amene matendawa ndi ofala kwambiri amayenera kulandira katemera wowonjezera pakapita nthawi, chomodzimodzinso ndi anthu omwe chitetezo chawo n'chochepa m'thupi.<!-- <ref name=WHO2009/> --> Anthu omwe sanalandire katemerayu koma apezeka m'dera limene  [[hepatitis B virus|mavailasi a hepataitisi B]] ndi ofala kwambiri akuyenera kulandira katemera wa [[hepatitis B immune globulin|hepataitisi B immune globulin]].<!-- <ref name=WHO2009/> --> Katemerayu amaperekedwa kudzera [[Intramuscular|m'jakisoni]].<ref name="WHO20092" /><!-- Safety and formulation -->

Serious side effects from the hepataitisi B katemera are very uncommon.<!-- <ref name=WHO2009/> --> Pain may occur at the site of injection.<!-- <ref name=WHO2009/> --> It is safe for use during [[pregnancy]] or while [[breastfeeding]].<!-- <ref name=WHO2009/> --> It has not been linked to [[Guillain-Barre syndrome]].<!-- <ref name=WHO2009/> --> The current katemeras are produced with [[recombinant DNA]] techniques.<!-- <ref name=WHO2009/> --> They are available both by themselves and in combination with other katemeras.<ref name="WHO20092" />

<!-- HIstory, society and culture -->
The first hepataitisi B katemera was approved in the United States in 1981.<ref>{{cite book|last1=Moticka|first1=Edward|title=A Historical Perspective on Evidence-Based Immunology|isbn=9780123983756|page=336|url=https://books.google.ca/books?id=2TMwAAAAQBAJ&pg=PA336}}</ref> A safer version came to market in 1986.<ref name="WHO20092" /> It is on the [[World Health Organization's List of Essential Medicines]], the most important medications needed in a basic [[health system]].<ref>{{cite web|title=WHO Model List of EssentialMedicines|url=http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1|work=World Health Organization|accessdate=22 April 2014|date=October 2013}}</ref> The wholesale cost is between 0.58 and 13.20 USD per dose as of 2014.<ref>{{cite web|title=Vaccine, Hepatitis B|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=HEPBV&s_year=2014&year=2014&str=&desc=Vaccine%2C%20Hepatitis%20B&pack=new&frm=VIAL&rte=INJ&class_code2=19%2E3%2E&supplement=&class_name=%2819%2E3%2E%29Vaccines%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=6 December 2015}}</ref> In the United States it costs between 50 and 100 USD.<ref name="Ric2015">{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=314}}</ref>

== References ==
<references />
[[Category:Pages with unreviewed translations]]
